Speaking AnxietySocial CommunicationImplementation

Pilot RCT (n=44): brief self-guided VR exposure for social anxiety produced lasting moderate-to-large gains

Zainal NH et al. · 2021 · Behaviour Research and Therapy · RCT · n = 44 · Adults with social anxiety disorder · DOI
Evidence certainty: Moderate certainty
How this was rated

Pre-specified RCT design with MINI structured-interview-confirmed SAD diagnoses, formal randomization, and pre/post/3-month/6-month outcome assessment. Effect sizes are moderate-to-large (g = 0.54 to 1.11) and reasonable for a pilot. Peer-reviewed in Behavior Research and Therapy (Elsevier, established high-impact peer-reviewed clinical-psychology venue). Piecewise multilevel modeling appropriate to the longitudinal design. Limitations: n=44 is pilot-scale (26 vs 18) - underpowered for some secondary comparisons. Waitlist comparator (not active) limits inference to 'better than no treatment' rather than 'as good as therapist-led VRET or CBT'. Self-reported outcomes dominate. Self-guided protocol (no therapist contact during sessions) is a strength for scalability but a limitation for treatment-fidelity inference - the clinical content delivered depends entirely on the materials and the participant's engagement.

Ratings use a simplified four-tier scheme (High, Moderate, Low, Very Low) informed by the GRADE working group. Learn more about how studies are rated.

Forty-four community-dwelling or undergraduate adults diagnosed with social anxiety disorder (SAD) using the Mini International Neuropsychiatric Interview were randomly assigned to a self-directed VR exposure intervention (designed to last four sessions or more; n=26) or a waitlist control (n=18). Outcomes measured at baseline, post-treatment, 3-month follow-up, and 6-month follow-up. VR exposure produced moderate-to-large reductions in SAD symptom severity, job interview fear, and trait worry (Hedges' g = 0.54 to 1.11). Although between-group differences in depression were not significant, the VR arm reduced depression while waitlist did not. Gains were maintained at 3- and 6-month follow-up. Self-reported presence increased during treatment (g = 0.36 to 0.45); cybersickness decreased (g = 0.43).

Clinical bottom line

A pilot RCT (n=44) demonstrating that BRIEF, SELF-GUIDED virtual reality exposure therapy can produce moderate-to-large reductions in social anxiety disorder severity and comorbid worry, with gains maintained at 3 and 6 months. The self-guided format - participants used VR exposure without therapist supervision after initial instruction - is critical for scalability and accessibility. For clinicians considering self-administered VRET as a stepped-care first line or between-session homework adjunct, this RCT is foundational. For people with stuttering (PWS) with SAD comorbidity, self-guided VR exposure between SLP sessions could augment in-session work. Caveat: pilot-scale RCT - replication with larger samples and active comparators is needed before recommending as primary treatment.

Key findings

  • 44 community-dwelling or undergraduate adults diagnosed with social anxiety disorder (SAD) using the MINI structured interview - clinical-diagnostic sample, not analogue or subclinical
  • Random allocation: self-directed VRE (designed for at least 4 sessions; n=26) vs waitlist (n=18)
  • PRIMARY: greater reductions in SAD symptom severity (Social Phobia Diagnostic Questionnaire, Social Interaction Anxiety Scale) and job interview fear (Measure of Anxiety in Selection Interviews) with moderate-to-large effects: Hedges' g = 0.54 to 1.11 (pre-to-post)
  • SECONDARY: trait worry (Penn State Worry Questionnaire) also showed significant reduction - VRE benefits extended beyond the social-anxiety target
  • Depression (Patient Health Questionnaire-9): NO between-group significance, but VRE arm reduced depression while waitlist did not - direction-consistent with the social-anxiety effects
  • DURABILITY: gains maintained at 3-month follow-up (3MFU) and 6-month follow-up (6MFU) - not transient
  • Sense of PRESENCE increased during VRE: facets of presence g = 0.36 to 0.45 - participants engaged with the virtual environment more deeply over sessions
  • CYBERSICKNESS decreased during VRE: g = 0.43 - habituation to VR, not increasing tolerance issues
  • Self-guided format - participants used VR exposure WITHOUT therapist supervision during sessions after initial instruction. Critical for scalability and stepped-care models

Background

By 2021, therapist-led VRET for social anxiety disorder had a substantial evidence base (Anderson 2013, Bouchard 2017, Klinger 2005, Kampmann 2016). However, therapist-led VRET requires specialist clinician time, which limits scalability and access. The next translational step was to test SELF-GUIDED VRET - exposure work conducted without therapist supervision during sessions - as a candidate for stepped-care delivery, between-session homework, and home-based self-help.

Most prior VRET trials embedded the exposure work within therapist sessions. The clinical question Zainal et al. set out to answer: can VRET work clinically when participants run it themselves?

What the researchers did

Forty-four community-dwelling or undergraduate adults diagnosed with SAD using the MINI structured clinical interview were randomly allocated to:

  1. Self-directed VR exposure (designed for at least four sessions; n=26)
  2. Waitlist control (n=18)

Self-reported SAD severity (Social Phobia Diagnostic Questionnaire, Social Interaction Anxiety Scale), job interview anxiety (Measure of Anxiety in Selection Interviews), trait worry (Penn State Worry Questionnaire), and depression (Patient Health Questionnaire-9) were measured at baseline, post-treatment, 3-month follow-up (3MFU), and 6-month follow-up (6MFU). Piecewise multilevel modeling managed clustering in the longitudinal data.

What they found

Why this matters

For clinicians and product teams thinking about scalable, accessible VRET for social anxiety, this is the foundational evidence that self-guided VR exposure works. The protocol does not require therapist contact during sessions - critical for stepped-care models, between-session homework augmentation, and home self-help.

For PWS with SAD comorbidity, self-guided VR exposure between SLP sessions could augment in-session social-communication work without consuming clinician time. The presence increase + cybersickness decrease pattern is reassuring for sustained engagement.

Limitations

Implications for practice

For clinicians considering self-administered or stepped-care VRET, this RCT is foundational evidence that brief self-guided VR exposure - without therapist supervision during sessions - can produce moderate-to-large gains for clinically diagnosed SAD with durable 3-6 month maintenance. Clinical applications include: (1) a low-intensity first-line option for clients on therapy waiting lists, (2) between-session homework adjunct to standard CBT or SLT, (3) self-administered home programs for clients with mild-to-moderate SAD who would not present to specialist services. For PWS with SAD comorbidity, self-guided VR exposure between SLP sessions could augment in-session social-communication work without requiring additional clinician time. Caveats: pilot-scale, waitlist comparator only, self-reported outcomes dominant. Replication with larger samples and active comparators (e.g., self-guided text-based CBT, therapist-led VRET) is needed before this becomes recommended primary treatment.

Related Studies

Social CommunicationSpeaking AnxietyGeneralization

VR exposure is as effective as in vivo exposure group therapy for public-speaking-focused social anxiety, with lasting results

In a randomized controlled trial of 97 adults with social anxiety disorder whose primary fear was public speaking, eight sessions of virtual reality exposure were as effective as eight sessions of manualized in vivo exposure delivered in groups. Both active treatments outperformed waitlist on self-report and on a behavioral speech task, and improvements were maintained at 12-month follow-up.

Anderson PL et al. · 2013 Read Summary
Speaking AnxietySocial CommunicationGeneralization

Three-arm RCT: CBT with VR exposure beat in-vivo exposure for social anxiety and was easier for therapists

A pre-registered three-arm RCT randomized 59 adults with DSM-5 social anxiety disorder to 14 weekly sessions of CBT with VR exposure (n=17), CBT with in-vivo exposure (n=22), or waitlist (n=20). The pre-specified superiority hypothesis was confirmed: VR exposure was significantly more effective than in-vivo exposure on the LSAS-SR primary outcome at post-treatment and at 6-month follow-up, and significantly less cumbersome for therapists (SWEAT: 15.24 vs 24.46). Reliable change: 76.5% VR, 68.3% in vivo, 30.0% waitlist.

Bouchard S et al. · 2017 Read Summary
Speaking AnxietySocial Communication

Pilot waitlist study: four brief VR therapy sessions cut public speaking anxiety in university students

Eight university students with public speaking anxiety completed four brief VR therapy sessions (~15 minutes each, weekly), with six waitlist-control students completing post-testing only. Self-report inventories, Subjective Units of Discomfort during exposure, and heart-rate measurements during speaking tasks were used. Results showed reductions on self-report measures and physiological indices for the VR group, supporting brief VRT as a workable PSA intervention. Small samples and pre-post-with-waitlist (not full RCT) design limit certainty - this is foundational pilot evidence rather than definitive efficacy data.

Harris SR et al. · 2002 Read Summary
Speaking AnxietySocial Communication

Three-arm RCT (n=60): in-vivo exposure outperformed VR exposure for social anxiety on several outcomes

Sixty participants diagnosed with social anxiety disorder were randomly assigned to individual virtual reality exposure therapy (VRET), individual in-vivo exposure therapy (iVET), or a waiting-list control. Both treatments improved social anxiety symptoms, speech duration, perceived stress, and avoidant-personality-disorder beliefs versus waitlist. However, iVET (but NOT VRET) also improved fear of negative evaluation, speech performance, general anxiety, depression, and quality of life. iVET was superior to VRET on social anxiety symptoms at post and follow-up and on avoidant-PD beliefs at follow-up. At follow-up, almost all improvements remained significant for iVET; for VRET only the perceived-stress effect held.

Kampmann IL et al. · 2016 Read Summary
Speaking AnxietySocial Communication

Preliminary controlled study (n=36): VR therapy matched group CBT for social phobia, with trivial differences

Thirty-six participants diagnosed with social phobia were allocated to either virtual reality therapy (VRT) using four virtual environments (performance, intimacy, scrutiny, assertiveness situations) OR a control condition of group cognitive-behavioral therapy (CBT). Both treatments lasted 12 weeks and were delivered according to a treatment manual. Both produced statistically and clinically significant improvement. Effect-size comparisons revealed that the differences between VRT and the active group-CBT comparator were trivial - establishing VRT as a non-inferior alternative to evidence-based group-CBT for social phobia.

Klinger E et al. · 2005 Read Summary
Speaking AnxietyImplementation

First RCT showing consumer VR delivers effective one-session exposure for public speaking anxiety, in clinic or at home

Twenty-five participants were randomized to one-session therapist-led VR exposure therapy for public speaking anxiety using consumer VR hardware and software, followed by a 4-week internet-administered VR-to-in-vivo transition program; another 25 served as a waiting-list. Therapist-led VRET produced a very large effect on self-reported PSA (within Cohen's d = 1.67). The waiting-list then received internet-administered, SELF-LED VRET at home, followed by the same transition program - producing a large effect (d = 1.35). Results were maintained or improved at 6-month and 12-month follow-ups. This is the first published RCT demonstrating that off-the-shelf consumer VR hardware and software can deliver effective PSA exposure therapy in both clinician-supervised and home-based formats.

Lindner P et al. · 2019 Read Summary
Speaking AnxietyEcological Validity

Three-arm RCT (n=51): stand-alone 360-degree video VR exposure cut public speaking anxiety versus no-treatment control

Fifty-one participants with high public speaking anxiety were randomly allocated to one of three conditions: 360° video VRET incorporating audience stimuli (n=17), 360° video VRET incorporating empty-room stimuli (n=16), or no-treatment control (n=18). Outcomes measured at five timepoints. Mixed-ANOVA revealed a significant time × intervention-group interaction for PSA, social anxiety, and fear of negative evaluation (FNE). Both 360° VRET groups showed large pre-to-post reductions; for PSA, partial η² = .90 (audience) and .71 (empty room). Active intervention participants showed continued significant improvement out to 10-week follow-up. The study also addresses whether 360° video content (audience vs empty room) affects VRET outcomes - both worked.

Reeves R et al. · 2021 Read Summary
Speaking AnxietyGeneralization

VR exposure equals traditional CBT for public-speaking anxiety, with lower dropout

In an 88-person RCT, VR-based cognitive-behavioral therapy for public-speaking anxiety produced anxiety reductions equivalent to traditional CBT and significantly larger than waitlist, with notably fewer participants dropping out of the VR arm.

Wallach HS et al. · 2009 Read Summary

Cite this study

If you reference this study in your work, the canonical citation formats are:

APA 7th
Zainal, N. H., Chan, W. W., Saxena, A. P., Taylor, C. B., & Newman, M. G. (2021). Pilot randomized trial of self-guided virtual reality exposure therapy for social anxiety disorder. Behaviour Research and Therapy. https://doi.org/10.1016/j.brat.2021.103984.
AMA 11th
Zainal NH, Chan WW, Saxena AP, Taylor CB, Newman MG. Pilot randomized trial of self-guided virtual reality exposure therapy for social anxiety disorder. Behaviour Research and Therapy. 2021. doi:10.1016/j.brat.2021.103984.
BibTeX
@article{zainal2021,
  author = {Zainal, N. H. and Chan, W. W. and Saxena, A. P. and Taylor, C. B. and Newman, M. G.},
  title = {Pilot randomized trial of self-guided virtual reality exposure therapy for social anxiety disorder},
  journal = {Behaviour Research and Therapy},
  year = {2021},
  doi = {10.1016/j.brat.2021.103984},
  url = {https://withvr.app/evidence/studies/zainal-2021}
}
RIS
TY  - JOUR
AU  - Zainal, N. H.
AU  - Chan, W. W.
AU  - Saxena, A. P.
AU  - Taylor, C. B.
AU  - Newman, M. G.
TI  - Pilot randomized trial of self-guided virtual reality exposure therapy for social anxiety disorder
JO  - Behaviour Research and Therapy
PY  - 2021
DO  - 10.1016/j.brat.2021.103984
UR  - https://withvr.app/evidence/studies/zainal-2021
ER  -

Know of research that should be in this hub? If a relevant peer-reviewed study is not listed here, send the reference to hello@withvr.app. The hub is kept up to date as the literature grows.

Funding & independence

Affiliations: The Pennsylvania State University; Palo Alto University; Stanford University. Funding sources not extracted in detail from the abstract excerpt. Peer-reviewed in Behavior Research and Therapy (Elsevier). No withVR BV involvement in funding, study design, or authorship. Summary prepared independently by withVR using the published peer-reviewed paper. The VR system used was a self-administered consumer-grade VR platform with structured exposure content, NOT Therapy withVR or Research withVR.

Last reviewed: 2026-05-17 Next review due: 2027-05-17 Reviewed by: Gareth Walkom